- Home
- ITCI vs KMX Comparison
ITCI vs KMX Comparison
Compare ITCI & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- KMX
- Stock Information
- Founded
- ITCI 2002
- KMX 1993
- Country
- ITCI United States
- KMX United States
- Employees
- ITCI N/A
- KMX N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- KMX Retail-Auto Dealers and Gas Stations
- Sector
- ITCI Health Care
- KMX Consumer Discretionary
- Exchange
- ITCI Nasdaq
- KMX Nasdaq
- Market Cap
- ITCI 13.5B
- KMX 12.6B
- IPO Year
- ITCI N/A
- KMX 1997
- Fundamental
- Price
- ITCI $126.97
- KMX $84.17
- Analyst Decision
- ITCI Buy
- KMX Buy
- Analyst Count
- ITCI 13
- KMX 12
- Target Price
- ITCI $103.62
- KMX $85.58
- AVG Volume (30 Days)
- ITCI 5.8M
- KMX 1.6M
- Earning Date
- ITCI 02-20-2025
- KMX 12-19-2024
- Dividend Yield
- ITCI N/A
- KMX N/A
- EPS Growth
- ITCI N/A
- KMX N/A
- EPS
- ITCI N/A
- KMX 2.93
- Revenue
- ITCI $613,728,000.00
- KMX $27,796,200,000.00
- Revenue This Year
- ITCI $48.43
- KMX N/A
- Revenue Next Year
- ITCI $38.10
- KMX $3.36
- P/E Ratio
- ITCI N/A
- KMX $28.68
- Revenue Growth
- ITCI 46.08
- KMX N/A
- 52 Week Low
- ITCI $62.78
- KMX $65.83
- 52 Week High
- ITCI $128.00
- KMX $91.25
- Technical
- Relative Strength Index (RSI)
- ITCI 84.04
- KMX 54.58
- Support Level
- ITCI $126.88
- KMX $82.97
- Resistance Level
- ITCI $127.36
- KMX $88.87
- Average True Range (ATR)
- ITCI 0.44
- KMX 1.79
- MACD
- ITCI -0.90
- KMX 0.35
- Stochastic Oscillator
- ITCI 55.86
- KMX 56.52
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About KMX CarMax Inc
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue (79% in fiscal 2024 due to the chip shortage) and wholesale about 13% (19% in fiscal 2024), with the remaining portion composed of extended service plans and repair. In fiscal 2024, the company retailed and wholesaled 765,572, and 546,331 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in 2023. It seeks over 5% share a few years from now. CarMax is based in Richmond, Virginia.